Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,040.00
0.00 (0.00%)
At close: Sep 8, 2025

Yungjin Pharm. Revenue

Yungjin Pharm. had revenue of 38.98B KRW in the quarter ending September 30, 2013, with 4.67% growth. This brings the company's revenue in the last twelve months to 158.79B, up 23.36% year-over-year. In the year 2012, Yungjin Pharm. had annual revenue of 137.69B with 22.82% growth.

Revenue (ttm)
158.79B
Revenue Growth
+23.36%
P/S Ratio
2.35
Revenue / Employee
276.63M
Employees
574
Market Cap
373.10B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2012137.69B25.58B22.82%
Dec 31, 2011112.11B-4.21B-3.62%
Dec 31, 2010116.32B12.94B12.52%
Dec 31, 2009103.38B-7.53B-6.79%
Dec 31, 2008110.91B1.25B1.14%
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Dec 31, 2004 Pro Pro Pro
Dec 31, 1999 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
PharmaResearch449.81B
ABL Bio94.93B
Revenue Rankings